|
OMIM |
Link |
Information gain |
01 |
|
HBFQTL2
|
[NCBI]
|
0.0569508
|
|
|
HBFQTL4
|
[NCBI]
|
0.00742358
|
|
|
HBFQTL3
|
[NCBI]
|
0.00470097
|
|
|
HBFQTL1
|
[NCBI]
|
0.00444181
|
|
|
HBG1
|
[NCBI]
|
0.00200395
|
|
|
HBG2
|
[NCBI]
|
0.00198816
|
|
|
sickle cell anemia
|
[NCBI]
|
0.00160041
|
|
|
HBB
|
[NCBI]
|
0.000756441
|
|
|
hemoglobin--variants for which the chain carrying the mutation is unknown or uncertain
|
[NCBI]
|
0.000518432
|
|
|
thalassemia, beta+, silent allele
|
[NCBI]
|
0.00037627
|
|
|
HBA1
|
[NCBI]
|
0.000198652
|
|
|
HBZ
|
[NCBI]
|
0.000198193
|
|
|
HBFQTL5
|
[NCBI]
|
0.00015664
|
|
|
HBD
|
[NCBI]
|
0.000144245
|
|
|
SLE
|
[NCBI]
|
0.000139299
|
|
|
thalassemias
|
[NCBI]
|
0.000125072
|
|
|
SDS
|
[NCBI]
|
0.00012074
|
|
|
JMML
|
[NCBI]
|
0.000113672
|
|
|
thrombocytopenia, platelet dysfunction, hemolysis, and imbalanced globin synthesis
|
[NCBI]
|
0.000113172
|
|
|
HBE1
|
[NCBI]
|
0.000111828
|
|
|
beta thalassemia, dominant inclusion body type
|
[NCBI]
|
9.97171e-05
|
|
|
DBA
|
[NCBI]
|
9.96196e-05
|
|
|
pearson marrow-pancreas syndrome
|
[NCBI]
|
7.48506e-05
|
|
|
EPO
|
[NCBI]
|
6.08854e-05
|
|
|
CF
|
[NCBI]
|
5.8884e-05
|
|
|
malaria, susceptibility to
|
[NCBI]
|
5.81702e-05
|
|
|
OCA1A
|
[NCBI]
|
5.81702e-05
|
|
|
locus control region, beta
|
[NCBI]
|
5.38939e-05
|
|
|
HBA2
|
[NCBI]
|
3.65734e-05
|
|
|
KLF1
|
[NCBI]
|
2.90733e-05
|
|
|
BCL11A
|
[NCBI]
|
2.27897e-05
|
|
|
HBQ1
|
[NCBI]
|
2.13596e-05
|
|
|
HPR
|
[NCBI]
|
2.02356e-05
|
|
|
DNMT1
|
[NCBI]
|
1.78932e-05
|
|
|
IKZF1
|
[NCBI]
|
1.78399e-05
|
|
|
AT
|
[NCBI]
|
1.63713e-05
|
|
|
PRL
|
[NCBI]
|
1.4144e-05
|
|
|
TIMP1
|
[NCBI]
|
1.3674e-05
|
|
|
GATA1
|
[NCBI]
|
1.35336e-05
|
|
|
G6PD
|
[NCBI]
|
1.26115e-05
|
|
|
AFP
|
[NCBI]
|
1.15756e-05
|
|
|
AQP1
|
[NCBI]
|
8.77806e-06
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
4.37044e-06
|
|
|
POMC
|
[NCBI]
|
2.88549e-07
|
|
|
ADA
|
[NCBI]
|
1.27933e-08
|
|